Daniel B. Mark
Duke University
Internal medicineSurgeryCardiologyRandomized controlled trialIntensive care medicinePhysical therapyEmergency medicineHazard ratioSudden cardiac deathCardiac catheterizationHeart failureCoronary artery diseaseAnginaRevascularizationAngioplastyIn patientMyocardial infarctionClinical trialMedicineEjection fraction
657Publications
136H-index
60.2kCitations
Publications 662
Newest
#1Harmony R. ReynoldsH-Index: 37
#2Leslee J. Shaw (NewYork–Presbyterian Hospital)H-Index: 31
Last. Zhen Huang (Durham University)H-Index: 16
view all 23 authors...
Background: The ISCHEMIA trial (International Study of Comparative Health Effectiveness With Medical and Invasive Approaches) postulated that patients with stable coronary artery disease (CAD) and ...
3 CitationsSource
#1Jose Lopez-Sendon (Hospital Universitario La Paz)H-Index: 85
#2Derek D. Cyr (Duke University)H-Index: 17
Last. Marcin DemkowH-Index: 18
view all 27 authors...
Aims null The International Study of Comparative Health Effectiveness with Medical and Invasive Approaches (ISCHEMIA) trial prespecified an analysis to determine whether accounting for recurrent cardiovascular events in addition to first events modified understanding of the treatment effects. null Methods and results null Patients with stable coronary artery disease (CAD) and moderate or severe ischaemia on stress testing were randomized to either initial invasive (INV) or initial conservative (...
Source
#1Monique A. Starks (Duke University)H-Index: 7
#2Larry R. Jackson (Duke University)H-Index: 10
Last. Jeanne E. Poole (UW: University of Washington)H-Index: 50
view all 13 authors...
Abstract null null Background null Patients with sudden cardiac arrest occurring in the acute phase of myocardial infarction (MI-SCA) are believed to be at similar risk of death after revascularization compared with MI patients without SCA (MI-no SCA). Among patients with anterior MI, we examined whether those with MI-SCA were at greater risk of all-cause mortality or sudden cardiac death (SCD) than MI-no SCA patients. null null null Methods null The Home Automated External Defibrillator Trial e...
Source
#1Derek S. Chew (Duke University)H-Index: 4
#2Daniel B. Mark (Duke University)H-Index: 136
Source
#1Emily P. ZeitlerH-Index: 13
#2Andrea M. RussoH-Index: 31
Last. Daniel B. MarkH-Index: 136
view all 7 authors...
Source
5 CitationsSource
#1Douglas L. PackerH-Index: 76
#2Tristram D. BahnsonH-Index: 24
Last. Daniel B. MarkH-Index: 136
view all 8 authors...
Source
#1Derek P. ChewH-Index: 65
Last. Melissa A. GreinerH-Index: 25
view all 11 authors...
Source
#1Kevin L. Thomas (Duke University)H-Index: 21
#2Hussein R. Al-Khalidi (Duke University)H-Index: 41
Last. Cabana InvestigatorsH-Index: 1
view all 9 authors...
Abstract null null Background null Rhythm control strategies for atrial fibrillation (AF), including catheter ablation, are substantially underused in racial/ethnic minorities in North America. null null null Objectives null This study sought to describe outcomes in the CABANA trial as a function of race/ethnicity. null null null Methods null CABANA randomized 2,204 symptomatic participants with AF to ablation or drug therapy including rate and/or rhythm control drugs. Only participants in North...
1 CitationsSource
#1Benjamin A. Steinberg (UofU: University of Utah)H-Index: 31
#2Zhen Li (Duke University)
Last. Jonathan P. Piccini (Duke University)H-Index: 81
view all 10 authors...
Abstract Background Atrial fibrillation (AF) and heart failure (HF) often accompany one another and each is independently associated with poor outcomes. However, the association between AF burden and outcomes is poorly understood. Objectives We aimed to describe the association between device-based AF burden and HF clinical outcomes. Methods We used a nationwide, remote monitoring database of cardiac implantable electronic devices (CIEDs), linked to Medicare claims. We included patients with non...
3 CitationsSource